Encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development, claims Roots Analysis


Posted July 29, 2021 by jameshebrew

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers.

 
To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this link

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments:
 Type of licensing deal payment
 Upfront payment
 Milestone payment

 Therapeutic area
 Metabolic disorder
 Neurological disorder
 Ophthalmic disorder
 Oncological disorder

 Target disease indication
 Ataxia telangiectasia
 Breast cancer
 Diabetes
 Glaucoma
 Head and neck cancer
 Macular telangectasia
 Pancreatic cancer
 Parkinson's disease
 Retinitis pigmentosa

 Type of encapsulation material used
 Alginate-based microcapsule
 Cellulose hydrogel
 Medical-grade plastic
 Red blood cell

 Key geographical region
 North America
 Europe
 Asia-Pacific and rest of the world

The Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 report features the following companies, which we identified to be key players in this domain:
 ALTuCELL
 Azellon Cell Therapeutics
 Beta-Cell
 Betalin Therapeutics
 CellProtect Biotechnology
 Diatranz Otsuka
 Encellin
 EryDel
 Gloriana Therapeutics
 Living Cell Technologies
 MaxiVAX
 Neurotech Pharmaceuticals
 PharmaCyte Biotech
 Semma Therapeutics
 Sernova

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles

6. Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles

7. Patent Analysis

8. Clinical Trial Analysis

9. Recent Partnerships

10. Funding and Investment Analysis

11. Grant Analysis

12. Potential Strategic Partners

13. Market Forecast

14. Conclusion

15. Executive Insights

16. Appendix 1: Tabulated Data

17. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

You may also be interested in the following titles:
1. Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices
2. Endocannabinoid System Targeted Therapeutics Market, 2020-2030
3. Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis Private Limited Gaurav Chaudhary
Country India
Categories Biotech
Tags cell encapsulation , Encapsulation , Roots Analysis , Report , biotech
Last Updated July 29, 2021